Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade
Cancer Cell · 2024-03 · 42 (3) · 429-443.e4
DOI: 10.1016/j.ccell.2024.01.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2024-03. Verfasst von Barzin Y Nabet und 26 weiteren Autor:innen. Beteiligte Einrichtung: Genentech Inc., South San Francisco CA, USA. Electronic address: nabet.barzin@gene.com. Hauptthemen laut MEDLINE: Lung Neoplasms, Small Cell Lung Carcinoma. Die Arbeit wurde bisher 207-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: NCI NIH HHS, F. Hoffmann-La Roche, Genentech Inc.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Genentech Inc., South San Francisco CA, USA. Electronic address: nabet.barzin@gene.com.
- Genentech Inc., South San Francisco CA, USA.
- F. Hoffmann-La Roche Ltd, Basel, Switzerland.
- Genentech Inc., South San Francisco CA, USA; Rancho Biosciences, San Diego, CA, USA.
- Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
- Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, 6000 Harry Hines Blvd., Dallas, TX 75390-8593, USA; Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX 75390,…
Förderung
- NCI NIH HHS
- F. Hoffmann-La Roche
- Genentech Inc
Zitieren
APA
Nabet, B. Y., Hamidi, H., Lee, M. C., Banchereau, R., Morris, S., Adler, L., Gayevskiy, V., Elhossiny, A. M., Srivastava, M. K., Patil, N. S., Smith, K. A., Jesudason, R., Chan, C., Chang, P. S., Fernandez, M., Rost, S., McGinnis, L. M., Koeppen, H., Gay, C. M., …, & Shames, D. S. (2024). Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade. Cancer Cell, 42(3), 429-443.e4. https://doi.org/10.1016/j.ccell.2024.01.010
Vancouver
Nabet BY, Hamidi H, Lee MC, Banchereau R, Morris S, Adler L, et al. Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade. Cancer Cell. 2024;42(3):429-443.e4. doi:10.1016/j.ccell.2024.01.010
BibTeX
@article{Nabet2024,
author = {Nabet, Barzin Y and Hamidi, Habib and Lee, Myung Chang and Banchereau, Romain and Morris, Stefanie and Adler, Leah and Gayevskiy, Velimir and Elhossiny, Ahmed M and Srivastava, Minu K and Patil, Namrata S and Smith, Kiandra A and Jesudason, Rajiv and Chan, Caleb and Chang, Patrick S and Fernandez, Matthew and Rost, Sandra and McGinnis, Lisa M and Koeppen, Hartmut and Gay, Carl M and Minna, John D and Heymach, John V and Chan, Joseph M and Rudin, Charles M and Byers, Lauren A and Liu, Stephen V and Reck, Martin and Shames, David S},
title = {Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade},
journal = {Cancer Cell},
year = {2024},
volume = {42},
number = {3},
pages = {429--443.e4},
doi = {10.1016/j.ccell.2024.01.010}
}
EUVIMED